Foci of affected cells remain after surgery, threatening to relapse to two-thirds of patients. Only the rest is cured after surgery completely. Treatment of inoperable patients with pancreatic cancer is intended to improve the quality of life, their number exceeds the number of prescriptions for surgery. Radio and chemotherapy is developing rapidly. In the clinics of Israel, a tumor is destroyed annually in a hundred thousand patients( a one-day or a week hospital with hospitalization with high survival).
Pancreatic cancer: prognosis
According to experts, the peak of the disease falls on sixty-year-old men who become infected more often than women and young people( one and a half and a hundred times, respectively).Statistics argue that the annual number of cases( including fatalities) increases fourfold( over the last fifty years).This is due to the violation of the ecology, diet, deterioration in the quality of products. In Russia, a head, body and tail organ swelling according to statistics falls on eight people out of a hundred( in the capital there are three more people), in Sweden it reaches 18, England and Japan 16, the USA - 11.
For a type of cancer of the head of the pancreas, the forecast is the highest, from 70%, moreover, these are complex cases, often leading to the rejection of surgical intervention. The organ is intertwined with others, metastasis is observed in most of them, pure cut out of affected cells is unrealistic. Statistics recognize the leadership of the tumor head of the body in women and men.
Pancreatic Cancer: Survival of
Statistics count the percentage of deaths each year, deducing the average. Specialists created a classification in which the survival rate for pancreatic cancer is divided in time after surgery:
- five-year survival rate - exceeds 22%, if the disease is found in the early stage, decreases to 6% on average
- annual survival rate - no less than 27% for any detection period
Pancreatic cancer: statistics
Physicians register fixed tumors in fifteen percent, ductal tumors in eighty, all the rest falls on non-classified cases. The survival rate is approximately the same, as the increase in diagnostic capabilities( allow early detection of the disease) is compensated by the increase in the number of patients whose outlook is disappointing.
Prognosis for a pancreatic tumor
The head of the pancreas is affected most often. Diagnosis of the disease is difficult due to lack of severe symptoms and therefore always late. The prognosis for a pancreatic tumor, as well as its head and tail, is very poor.
Cancer removal operations are performed in 20% of patients. But to overcome the threshold in five years without relapse, only 8% of patients undergoing surgery can.
After the operation, 15% of patients are susceptible to hospital mortality. Complications in 100% of cases are relapses of the disease.90% of patients die after 1 year after the operative intervention.
Death in pancreatic cancer
Most often, a full complex of examinations is performed to determine the stage of the disease. There are 3 stages of the disease relative to the time of the operation.
At the first, operable stage, a cancerous tumor can spread beyond the border of the affected organ, but not touch the major blood vessels. This is the most difficult stage to diagnose. Cancer can be "caught" only in 10% of patients.
The second and third stages of the disease are inoperable. In the second stage, damage is captured by nearby organs. At the third metastatic stage, the disease affects the entire abdominal region. The mortality forecast for pancreatic cancer of the second and third stages reaches 100%.
Potentially resectable are 5% of patients with an organ swelling tumor. Jaundice is observed in 90% of the patients, and pain is only in 25%.The forecast for the potential lifespan, which doctors give, is basically about 20 months.
Tumor growth, leading to unresectability, is diagnosed in 46-50% of all patients. In these cases, the tumor is localized in the head. Up to 80% of patients suffer from severe pain. Only about 15% of patients tolerate the disease painlessly. In unresectable patients, jaundice is recorded in 75%.Death in pancreatic cancer in inoperable patients is predicted after approximately 7 months.
Remote metastasis in this disease is projected in 50% of patients. A tumor can be located in any part of the affected organ. It is found both in the head and body, and in the tail. All patients suffer from severe pain. The absence of pain symptoms was noted in 5% of patients. Jaundice is observed in 30% of patients. The lethal outcome comes in 2.5 months, on average.